Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation

Background. Multiple studies have failed to reveal an effective method for preventing the recurrence of primary sclerosing cholangitis (PSC) after liver transplantation (LTx). A national study conducted in Japan revealed several risk factors for the recurrence after living donor LTx (LDLTx); however...

Full description

Bibliographic Details
Main Authors: Yohei Yamada, MD, PhD, Ken Hoshino, MD, PhD, Yasushi Fuchimoto, MD, PhD, Kentaro Matsubara, MD, PhD, Taizo Hibi, MD, PhD, Hiroshi Yagi, MD, PhD, Yuta Abe, MD, PhD, Masahiro Shinoda, MD, PhD, Minoru Kitago, MD, PhD, Hideaki Obara, MD, PhD, Takahito Yagi, MD, PhD, Hideaki Okajima, MD, PhD, Toshimi Kaido, MD, PhD, Shinji Uemoto, MD, PhD, Tatsuya Suzuki, MD, PhD, Keiichi Kubota, MD, PhD, Tomoharu Yoshizumi, MD, Yoshihiko Maehara, MD, Yukihiro Inomata, MD, PhD, Yuko Kitagawa, MD, PhD, Hiroto Egawa, MD, PhD, Tatsuo Kuroda, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2018-02-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000760

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000760

Similar Items